---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-112038"
form_type: "8-K"
ticker: "SGHT"
cik: "0001531177"
company_name: "Sight Sciences, Inc."
filed_at: "2024-10-03T23:59:59+00:00"
generated_at: "2026-05-30T21:27:29.197562+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sight Sciences: Final Medicare LCDs confirm coverage for OMNI and SION procedures but impose usage limitations

## Summary
- Four MACs (Palmetto GBA, CGS, NGS, WPS) published final LCDs effective Nov 17, 2024, confirming coverage for single MIGS with phaco.
- Coverage continues for canaloplasty/trabeculotomy (OMNI) and goniotomy (SION) procedures.
- Limitations: non-coverage for first-line mild-to-moderate glaucoma, combined MIGS with aqueous shunt, and phaco with multiple MIGS.
- Sight Sciences plans to engage with MACs, CMS, and clinical societies on coverage issues.

## SEC filing metadata
- accession: 0000950170-24-112038
- form_type: 8-K
- ticker: SGHT
- cik: 0001531177
- company_name: Sight Sciences, Inc.
- filed_at: 2024-10-03T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531177/000095017024112038/0000950170-24-112038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531177/000095017024112038/sght-20241003.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-112038
- JSON: https://secwatch.observer/filing/0000950170-24-112038.json
- Plain text: https://secwatch.observer/filing/0000950170-24-112038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.